News
05-15-2014, 06:10 AM
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
More... (http://www.news-medical.net/news/20140515/VisionGate-develops-LuCED-test-for-early-detection-of-lung-cancer.aspx)
More... (http://www.news-medical.net/news/20140515/VisionGate-develops-LuCED-test-for-early-detection-of-lung-cancer.aspx)